Emergent BioSolutions Inc. (EBS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250M 500M 750M Q1 '10: 46.8M Q2 '10: 62.1M Q3 '10: 74M Q4 '10: 103.2M Q1 '11: 18.5M Q2 '11: 88.1M Q3 '11: 58.8M Q4 '11: 107.9M Q1 '12: 50.3M Q2 '12: 70.4M Q3 '12: 66.6M Q4 '12: 94.6M Q1 '13: 43.1M Q2 '13: 82.4M Q3 '13: 89.1M Q4 '13: 98.1M Q1 '14: 53.9M Q2 '14: 110.3M Q3 '14: 138M Q4 '14: 148M Q1 '15: 63.6M Q2 '15: 126.1M Q3 '15: 164.9M Q4 '15: 168.1M Q1 '16: 111M Q2 '16: 91.2M Q3 '16: 142.9M Q4 '16: 151.7M Q1 '17: 116.9M Q2 '17: 100.8M Q3 '17: 149.4M Q4 '17: 193.8M Q1 '18: 117.8M Q2 '18: 220.2M Q3 '18: 173.6M Q4 '18: 270.7M Q1 '19: 190.6M Q2 '19: 243.2M Q3 '19: 311.8M Q4 '19: 360.4M Q1 '20: 192.5M Q2 '20: 394.7M Q3 '20: 385.2M Q4 '20: 583M Q1 '21: 343M Q2 '21: 397.5M Q3 '21: 329M Q4 '21: 732.9M Q1 '22: 304.8M Q2 '22: 242.6M Q3 '22: 239.9M Q4 '22: 330.2M Q1 '23: 164.3M Q2 '23: 337.9M Q3 '23: 270.5M Q4 '23: 276.6M Q1 '24: 300.4M Q2 '24: 254.7M Q3 '24: 293.8M Q4 '24: 194.7M Q1 '25: 222.2M Q2 '25: 140.9M Q3 '25: 231.1M Q4 '25: 148.7M Q1 '26: 156.1M Q2 '26: 234.3M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

-150M 0 150M 300M 450M Q1 '15: -21.9M Q2 '15: 35.1M Q3 '15: 63.2M Q4 '15: 65.1M Q1 '16: 21.2M Q2 '16: -2M Q3 '16: 35.5M Q4 '16: 50.9M Q1 '17: 14.9M Q2 '17: 8.5M Q3 '17: 47.8M Q4 '17: 53.1M Q1 '18: -9.5M Q2 '18: 66.8M Q3 '18: 21.3M Q4 '18: 11.2M Q1 '19: -27.4M Q2 '19: -7M Q3 '19: 70.7M Q4 '19: 77.8M Q1 '21: 222.4M Q2 '21: 144.3M Q3 '21: 94.6M Q4 '21: 430M Q1 '22: 142M Q2 '22: 65.6M Q3 '22: 75.3M Q4 '22: 102.6M Q1 '23: 4.9M Q2 '23: 140.7M Q3 '23: 87.2M Q4 '23: 84.8M Q1 '24: 147.8M Q2 '24: -48M Q3 '24: 161.2M Q1 '16 Q2 '17 Q3 '18 Q4 '19 Q1 '22 Q2 '23 Q3 '24

Operating Income Quarterly

-300M -200M -100M 0 100M 200M 300M Q1 '10: 3.2M Q2 '10: 14.8M Q3 '10: 20.6M Q4 '10: 35M Q1 '11: -35.5M Q2 '11: 20.2M Q3 '11: 1.4M Q4 '11: 46M Q1 '12: -12.5M Q2 '12: 8.7M Q3 '12: 9.8M Q4 '12: 24M Q1 '13: -13.3M Q2 '13: 14.7M Q3 '13: 18.1M Q4 '13: 23.3M Q1 '14: -25.5M Q2 '14: 7.9M Q3 '14: 31M Q4 '14: 44.6M Q1 '15: -28.3M Q2 '15: 21.5M Q3 '15: 63.2M Q4 '15: 49.9M Q1 '16: 21.2M Q2 '16: -2M Q3 '16: 35.5M Q4 '16: 50.9M Q1 '17: 14.9M Q2 '17: 8.5M Q3 '17: 47.8M Q4 '17: 53.1M Q1 '18: -9.5M Q2 '18: 66.8M Q3 '18: 21.3M Q4 '18: 11.2M Q1 '19: -27.2M Q2 '19: -7M Q3 '19: 70.7M Q4 '19: 77.8M Q1 '20: -11.6M Q2 '20: 126M Q3 '20: 61.3M Q4 '20: 258.1M Q1 '21: 95.4M Q2 '21: 14.5M Q3 '21: -34.7M Q4 '21: 286.8M Q1 '22: 6.9M Q2 '22: -76.3M Q3 '22: -45.3M Q4 '22: -55.3M Q1 '23: -147.6M Q2 '23: -292.9M Q3 '23: -242.1M Q4 '23: -43.8M Q1 '24: 39.8M Q2 '24: -203.5M Q3 '24: 64.5M Q4 '24: -9.5M Q1 '25: 49.9M Q2 '25: 1.6M Q3 '25: 76.5M Q1 '26: 10.5M Q2 '26: -125.1M Q2 '10 Q3 '12 Q4 '14 Q1 '17 Q2 '19 Q3 '21 Q4 '23 Q2 '26

Net Income Quarterly

-300M -200M -100M 0 100M 200M 300M Q1 '10: 2.5M Q2 '10: 9.8M Q3 '10: 13.1M Q4 '10: 26.2M Q1 '11: -21.4M Q2 '11: 14.2M Q3 '11: 1.5M Q4 '11: 28.7M Q1 '12: -6.8M Q2 '12: 7.6M Q3 '12: 6.6M Q4 '12: 16.1M Q1 '13: -8.1M Q2 '13: 10.5M Q3 '13: 13.5M Q4 '13: 15.2M Q1 '14: -20.2M Q2 '14: 5M Q3 '14: 21.8M Q4 '14: 30.1M Q1 '15: -21.5M Q2 '15: 14.1M Q3 '15: 36.9M Q4 '15: 33.3M Q1 '16: 4M Q2 '16: -10.9M Q3 '16: 21.3M Q4 '16: 37.4M Q1 '17: 10.5M Q2 '17: 4.6M Q3 '17: 33.6M Q4 '17: 33.9M Q1 '18: -4.9M Q2 '18: 50.1M Q3 '18: 20.9M Q4 '18: -3.4M Q1 '19: -26M Q2 '19: -9.5M Q3 '19: 43.2M Q4 '19: 46.9M Q1 '20: -12.5M Q2 '20: 92.7M Q3 '20: 39.5M Q4 '20: 185.4M Q1 '21: 69.7M Q2 '21: 4.6M Q3 '21: -32.7M Q4 '21: 193.1M Q1 '22: -4.6M Q2 '22: -52.9M Q3 '22: -87.1M Q4 '22: -67M Q1 '23: -186.2M Q2 '23: -261.4M Q3 '23: -263.4M Q4 '23: -49.5M Q1 '24: 9M Q2 '24: -283.1M Q3 '24: 114.8M Q4 '24: -31.3M Q1 '25: 68M Q2 '25: -12M Q3 '25: 51.2M Q4 '25: -54.6M Q1 '26: 6.8M Q2 '26: -180.2M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 150M 300M 450M Q1 '17: 46.3M Q2 '17: 34.6M Q3 '17: 44.5M Q4 '17: 62.3M Q1 '18: 54.3M Q2 '18: 85.3M Q3 '18: 69.3M Q4 '18: 113.5M Q1 '19: 91.8M Q2 '19: 100.8M Q3 '19: 108M Q4 '19: 132.8M Q1 '20: 76.9M Q2 '20: 129.8M Q3 '20: 149M Q4 '20: 181.3M Q1 '21: 99.3M Q2 '21: 227.8M Q1 '22: 155.9M Q2 '22: 169.8M Q3 '22: 147.2M Q4 '22: 220.5M Q1 '23: 152.9M Q2 '23: 190.6M Q3 '23: 176.8M Q4 '23: 185.1M Q1 '24: 144.6M Q2 '24: 296.1M Q3 '24: 122.6M Q4 '24: 118M Q1 '25: 88.5M Q2 '25: 66.9M Q3 '25: 85.9M Q4 '25: 84.9M Q1 '26: 72M Q2 '26: 97.1M Q1 '17 Q2 '18 Q3 '19 Q4 '20 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-300M -150M 0 150M 300M 450M Q3 '10: 54.2M Q4 '10: 22.7M Q1 '11: -22.7M Q2 '11: -6.7M Q3 '11: 4.7M Q1 '12: 13.8M Q2 '12: 18.3M Q3 '12: 46.5M Q1 '13: -4.6M Q2 '13: 32.8M Q3 '13: 60.1M Q4 '13: 8.6M Q1 '14: -29.2M Q2 '14: 10.8M Q3 '14: 78.9M Q4 '14: 51.8M Q1 '15: -65.9M Q2 '15: 2.5M Q3 '15: 104.8M Q4 '15: 1.1M Q1 '16: 42.2M Q2 '16: -6.5M Q3 '16: 27.1M Q4 '16: -8.2M Q1 '17: 41.7M Q2 '17: 54M Q3 '17: 34.9M Q4 '17: 77.5M Q1 '18: -1M Q2 '18: 34.6M Q3 '18: 174M Q1 '19: 104.8M Q2 '19: -35.8M Q3 '19: -3.1M Q4 '19: 122.1M Q1 '20: 57.8M Q2 '20: 127.9M Q3 '20: 105.2M Q4 '20: 246M Q1 '21: 5.1M Q2 '21: -29.7M Q3 '21: 16.7M Q4 '21: 328.1M Q1 '22: -37.3M Q2 '22: -15.6M Q3 '22: -74M Q4 '22: 92.8M Q1 '23: -184M Q2 '23: -114.4M Q3 '23: 60M Q4 '23: 32.1M Q1 '24: -62.6M Q2 '24: 47.5M Q3 '24: 153.7M Q4 '24: -79.9M Q1 '25: -11.2M Q2 '25: 106.4M Q3 '25: -2.3M Q4 '25: 77.7M Q1 '26: -33.8M Q2 '26: 56.1M Q3 '11 Q1 '14 Q1 '16 Q1 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-200M -100M 0 100M 200M 300M Q3 '10: 48.8M Q4 '10: 14.6M Q1 '11: -31.2M Q2 '11: -15M Q3 '11: -12.7M Q1 '12: -8.5M Q2 '12: 9.7M Q3 '12: 36.5M Q1 '13: -12.3M Q2 '13: 26.4M Q3 '13: 39.8M Q4 '13: 1M Q1 '14: -33.8M Q2 '14: 6M Q3 '14: 73.7M Q4 '14: 35.8M Q1 '15: -75M Q2 '15: -8.1M Q3 '15: 90.8M Q4 '15: -10.1M Q1 '16: 24M Q2 '16: -27.5M Q3 '16: 10.1M Q4 '16: -28.1M Q1 '17: 21.4M Q2 '17: 44.7M Q3 '17: 22.2M Q4 '17: 65.1M Q1 '18: -12.6M Q2 '18: 21M Q3 '18: 147.9M Q1 '19: 83.4M Q2 '19: -49.9M Q3 '19: -18.4M Q4 '19: 86M Q1 '20: 33.6M Q2 '20: 92.8M Q3 '20: 59.5M Q4 '20: 209.1M Q1 '21: -51M Q2 '21: -96.7M Q3 '21: -38.5M Q4 '21: 282.3M Q1 '22: -69.5M Q2 '22: -47.7M Q3 '22: -101.9M Q4 '22: 69.2M Q1 '23: -199.1M Q2 '23: -126.9M Q3 '23: 47.4M Q4 '23: 20.7M Q1 '24: -73.4M Q2 '24: 42.9M Q3 '24: 147.9M Q4 '24: -81.6M Q1 '25: -14.8M Q2 '25: 103.5M Q3 '25: -5.7M Q4 '25: 73.8M Q1 '26: -36.2M Q2 '26: 54M Q3 '11 Q1 '14 Q1 '16 Q1 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '10: 31.9M Q3 '10: 32.1M Q1 '11: 35.2M Q2 '11: 36.7M Q3 '11: 36.4M Q1 '12: 36M Q2 '12: 36.6M Q3 '12: 36.7M Q1 '13: 36M Q2 '13: 36.5M Q3 '13: 37M Q1 '14: 36.9M Q2 '14: 38.3M Q3 '14: 46.6M Q1 '15: 37.9M Q2 '15: 47.4M Q3 '15: 47.8M Q1 '16: 48.4M Q2 '16: 40.2M Q3 '16: 49.4M Q1 '17: 49.7M Q2 '17: 50.1M Q3 '17: 50.5M Q1 '18: 49.6M Q2 '18: 51.2M Q3 '18: 51.5M Q1 '19: 51.2M Q2 '19: 51.5M Q3 '19: 52.3M Q1 '20: 52M Q2 '20: 53.5M Q3 '20: 54.3M Q1 '21: 54.5M Q2 '21: 54M Q3 '21: 53.7M Q1 '22: 50.7M Q2 '22: 50M Q3 '22: 49.9M Q1 '23: 50.2M Q2 '23: 50.7M Q3 '23: 51.8M Q1 '24: 52.2M Q2 '24: 52.6M Q3 '24: 55.6M Q1 '25: 57.3M Q2 '25: 54.2M Q3 '25: 56.5M Q1 '26: 56.5M Q2 '26: 51.6M Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q4 '10: 1.59 Q1 '11: 0.90 Q2 '11: 0.98 Q3 '11: 0.61 Q4 '11: 0.60 Q1 '12: 1.02 Q2 '12: 0.84 Q3 '12: 0.98 Q4 '12: 0.64 Q1 '13: 0.61 Q2 '13: 0.69 Q3 '13: 0.87 Q4 '13: 0.84 Q1 '14: 0.51 Q2 '14: 0.35 Q3 '14: 0.48 Q4 '14: 0.73 Q1 '15: 0.71 Q2 '15: 0.90 Q3 '15: 1.20 Q4 '15: 1.25 Q1 '16: 1.92 Q2 '16: 1.33 Q3 '16: 0.99 Q4 '16: 1.05 Q1 '17: 1.18 Q2 '17: 1.56 Q3 '17: 1.79 Q4 '17: 1.70 Q1 '18: 1.37 Q2 '18: 2.24 Q3 '18: 1.97 Q4 '18: 1.22 Q1 '19: 0.81 Q2 '19: -0.35 Q3 '19: 0.07 Q4 '19: 1.04 Q1 '20: 1.31 Q2 '20: 3.22 Q3 '20: 3.12 Q4 '20: 5.66 Q1 '21: 7.18 Q2 '21: 5.54 Q3 '21: 4.20 Q4 '21: 4.36 Q1 '22: 2.99 Q2 '22: 1.84 Q3 '22: 0.70 Q4 '22: -4.24 Q1 '23: -7.86 Q2 '23: -11.96 Q3 '23: -15.29 Q4 '23: -14.83 Q1 '24: -10.95 Q2 '24: -11.17 Q3 '24: -4.03 Q4 '24: -3.60 Q1 '25: -2.58 Q2 '25: 2.58 Q3 '25: 1.43 Q4 '25: 0.93 Q1 '26: -0.19 Q2 '26: -3.46 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.